Hyperinsulinemic Hypoglycemia Diagnosed in Childhood Can Be Monogenic

• Published in: The journal of clinical endocrinology and metabolism 2023-03, Vol.108 (3), p.680-687
• Main Authors: Hopkins, Jasmin J, Childs, Alexandra J, Houghton, Jayne A L, Hewat, Thomas I, Atapattu, Navoda, Johnson, Matthew B, Patel, Kashyap A, Laver, Thomas W, Flanagan, Sarah E
• Format: Article
• Language: English
• Subjects: Adolescent; Age; Age composition; Blood Glucose; Blood sugar; Child; Child, Preschool; Childhood; Children; Clinical; Congenital Hyperinsulinism - diagnosis; Congenital Hyperinsulinism - genetics; Diagnosis; Diseases; Genetic disorders; Genetic screening; Genetic Testing; Genotypes; Humans; Hyperinsulinism - complications; Hyperinsulinism - diagnosis; Hyperinsulinism - genetics; Hypoglycemia; Hypoglycemia - diagnosis; Hypoglycemia - genetics; Infant; Insulin secretion; Medical screening; Pancreatic Diseases - genetics
• ISSN: 0021-972X; 1945-7197
• DOI: 10.1210/clinem/dgac604

Abstract Context Congenital hyperinsulinism (HI) is characterized by inappropriate insulin secretion despite low blood glucose. Persistent HI is often monogenic, with the majority of cases diagnosed in infancy. Less is known about the contribution of monogenic forms of disease in those presenting in childhood. Objective We investigated the likelihood of finding a genetic cause in childhood-onset HI and explored potential factors leading to later age at presentation of disease. Methods We screened known disease-causing genes in 1848 individuals with HI, referred for genetic testing as part of routine clinical care. Individuals were classified as infancy-onset (diagnosed with HI < 12 months of age) or childhood-onset (diagnosed at age 1-16 years). We assessed clinical characteristics and the genotypes of individuals with monogenic HI diagnosed in childhood to gain insights into the later age at diagnosis of HI in these children. Results We identified the monogenic cause in 24% (n = 42/173) of the childhood-onset HI cohort; this was significantly lower than the proportion of genetic diagnoses in infancy-onset cases (74.5% [n = 1248/1675], P < 0.00001). Most (75%) individuals with genetically confirmed childhood-onset HI were diagnosed before 2.7 years, suggesting these cases represent the tail end of the normal distribution in age at diagnosis. This is supported by the finding that 81% of the variants identified in the childhood-onset cohort were detected in those diagnosed in infancy. Conclusion We have shown that monogenic HI is an important cause of hyperinsulinism presenting outside of infancy. Genetic testing should be considered in children with persistent hyperinsulinism, regardless of age at diagnosis.